PAM
CTKB icon

Panagora Asset Management’s Cytek Biosciences CTKB Stock Holding History

Panagora Asset Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Hold
51,593
– – ﹤0.01% 1064
2025
Q4 		$261K Sell
51,593
-11,005
-18% -$51.1K ﹤0.01% 1043
2025
Q3 		$217K Sell
62,598
-225,664
-78% -$847K ﹤0.01% 1072
2025
Q2 		$980K Sell
288,262
-120,664
-30% -$402K ﹤0.01% 631
2025
Q1 		$1.64M Buy
408,926
+281,928
+222% +$1.46M 0.01% 559
2024
Q4 		$824K Buy
+126,998
New +$757K ﹤0.01% 701

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return